BCTX (STOCKS)
Briacell Therapeutics Corp. Common Shares
$4.350000
+0.070000 (+1.64%)
Prev close: $4.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William V. Williams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31.89M
- Employees
- 4
- P/E (TTM)
- -0.16
- P/B (TTM)
- 1.00
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $278.67K |
| Operating Expenses | $30.74M |
| Research and Development | $24.66M |
| Other Operating Expenses | $6.16M |
| Operating Income/Loss | -$30.74M |
| Income/Loss Before Equity Method Investments | $23.36M |
| Income/Loss From Continuing Operations After Tax | $23.15M |
| Income/Loss From Continuing Operations Before Tax | $23.15M |
| Income/Loss From Equity Method Investments | -$216.94K |
| Net Income/Loss | -$29.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$326.60K |
| Net Income/Loss Attributable To Parent | -$29.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$29.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$64.06 |
| Diluted Earnings Per Share | -$64.06 |
| Basic Average Shares | 6,126,947 |
| Diluted Average Shares | 6,126,947 |
| Assets | $33.59M |
| Current Assets | $32.18M |
| Noncurrent Assets | $1.42M |
| Fixed Assets | $251.14K |
| Non-current Prepaid Expenses | $405.09K |
| Other Non-current Assets | $759.34K |
| Liabilities | $3.38M |
| Current Liabilities | $3.19M |
| Noncurrent Liabilities | $195.10K |
| Equity | $30.21M |
| Equity Attributable To Noncontrolling Interest | -$702.63K |
| Equity Attributable To Parent | $30.92M |
| Liabilities And Equity | $33.59M |
| Net Cash Flow From Operating Activities | -$30.97M |
| Net Cash Flow From Operating Activities, Continuing | -$30.97M |
| Net Cash Flow From Investing Activities | -$288.53K |
| Net Cash Flow From Investing Activities, Continuing | -$288.53K |
| Net Cash Flow From Financing Activities | $56.15M |
| Net Cash Flow From Financing Activities, Continuing | $56.15M |
| Net Cash Flow | $24.89M |
| Net Cash Flow, Continuing | $24.89M |
| Comprehensive Income/Loss | -$29.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$29.96M |
| Other Comprehensive Income/Loss | $0.00 |